4.8 Article

Age Distribution of Multiple Functionally Relevant Subsets of CD4+T Cells in Human Blood Using a Standardized and Validated 14-Color EuroFlow Immune Monitoring Tube

Journal

FRONTIERS IN IMMUNOLOGY
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.00166

Keywords

CD4+T-cell subsets; flow cytometry; immune monitoring; Tregs; TFH; Th-cell subsets; age-related values

Categories

Funding

  1. PERISCOPE project - Innovative Medicines Initiative 2 Joint Undertaking [115910]
  2. European Union
  3. European Federation of Pharmaceutical Industries and Associations (EFPIA)
  4. Bill and Melinda Gates Foundation (BMGF)
  5. EuroFlow Consortium
  6. FP6-2004-LIFESCIHEALTH-5 program of the European Commission [LSHB-CT-2006-018708]
  7. Biomedical Research Networking Center Consortium (CIBER-CIBERONC) [CB16/12/00400FEDER]
  8. Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia, Innovacion y Universidades (Madrid, Spain) [PI17/00399-FEDER, PI19/01166FEDER]
  9. Fundacion Mutua Madrilena (Madrid, Spain)
  10. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes, Brazil) [207555/2015-0]
  11. Agencia Estatal de Investigacion (Ministerio de Ciencia, Innovacion y Universidades, Spain) [DI-17-09591]

Ask authors/readers for more resources

CD4+ T cells comprise multiple functionally distinct cell populations that play a key role in immunity. Despite blood monitoring of CD4+ T-cell subsets is of potential clinical utility, no standardized and validated approaches have been proposed so far. The aim of this study was to design and validate a single 14-color antibody combination for sensitive and reproducible flow cytometry monitoring of CD4+ T-cell populations in human blood to establish normal age-related reference values and evaluate the presence of potentially altered profiles in three distinct disease models-monoclonal B-cell lymphocytosis (MBL), systemic mastocytosis (SM), and common variable immunodeficiency (CVID). Overall, 145 blood samples from healthy donors were used to design and validate a 14-color antibody combination based on extensive reagent testing in multiple cycles of design-testing-evaluation-redesign, combined with in vitro functional studies, gene expression profiling, and multicentric evaluation of manual vs. automated gating. Fifteen cord blood and 98 blood samples from healthy donors (aged 0-89 years) were used to establish reference values, and another 25 blood samples were evaluated for detecting potentially altered CD4 T-cell subset profiles in MBL (n = 8), SM (n = 7), and CVID (n = 10). The 14-color tube can identify >= 89 different CD4+ T-cell populations in blood, as validated with high multicenter reproducibility, particularly when software-guided automated (vs. manual expert-based) gating was used. Furthermore, age-related reference values were established, which reflect different kinetics for distinct subsets: progressive increase of naive T cells, T-helper (Th)1, Th17, follicular helper T (TFH) cells, and regulatory T cells (Tregs) from birth until 2 years, followed by a decrease of naive T cells, Th2, and Tregs in older children and a subsequent increase in multiple Th-cell subsets toward late adulthood. Altered and unique CD4+ T-cell subset profiles were detected in two of the three disease models evaluated (SM and CVID). In summary, the EuroFlow immune monitoring TCD4 tube allows fast, automated, and reproducible identification of >= 89 subsets of CD4+ blood T cells, with different kinetics throughout life. These results set the basis for in-depth T-cell monitoring in different disease and therapeutic conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available